4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0001062993-21-000275
10% owner bought 1,050,000 shares at an average $8.76 ($9,202,668)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC 10% owner | 2021-01-07 | Purchase | +500,000 | $8.13 | $4,065,000 | 6,785,458 | I: show line 1 in the form |
| PERCEPTIVE ADVISORS LLC 10% owner | 2021-01-08 | Purchase | +347,332 | $9.21 | $3,198,928 | 7,132,790 | I: show line 2 in the form |
| PERCEPTIVE ADVISORS LLC 10% owner | 2021-01-08 | Purchase | +152,668 | $10.21 | $1,558,740 | 7,285,458 | I: show line 3 in the form |
| PERCEPTIVE ADVISORS LLC 10% owner | 2021-01-08 | Purchase | +50,000 | $7.60 | $380,000 | 7,335,458 | I: show line 4 in the form |
| Open-market purchases · 1,050,000 sh · avg $8.76 · $9,202,668 | |||||||
Loading xslF345X03/form4.xml…